Business Context and Reporting Period
This Form 8-K Current Report from Bionano Genomics, Inc. (BNGO) covers events occurring on May 5, 2026. The filing details a significant leadership transition involving the termination of the President and Chief Executive Officer and the appointment of an interim successor.
Key Financial Metrics
The filing does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on corporate governance and executive compensation changes.
- Interim CEO Base Salary: $600,000 annually.
- Interim CEO Bonus Opportunity: Up to $400,000 (2026 annualized, pro-rated).
- Interim CEO Stipend: $4,000 per month for housing and travel.
- Outgoing CEO Severance: Entitled to benefits per employment agreement, subject to release execution.
Material Changes
The primary material change is the immediate termination of R. Erik Holmlin, Ph.D., as President and Chief Executive Officer, effective May 5, 2026. Dr. Holmlin also resigned from the Board of Directors and all committees. He is expected to enter a consulting agreement to assist with the transition.
Guidance, Outlook, and Management Commentary
The Board appointed Albert A. Luderer, Ph.D., the current Chairman of the Board, as Interim Chief Executive Officer and Interim Principal Financial Officer. Dr. Luderer will no longer serve on the Compensation, Audit, or Nominating and Corporate Governance Committees. The Company intends to promptly commence a search for a permanent CEO. Additionally, Christopher J. Twomey was appointed as Lead Independent Director and a member of the Compensation Committee.
Investor Verification Checklist
- Verify the terms of the severance agreement for the outgoing CEO, Dr. Holmlin, once filed.
- Review the full text of the Offer Letter for Dr. Luderer (to be filed in a future report) for detailed compensation terms.
- Monitor the timeline and criteria for the search for a permanent Chief Executive Officer.
- Confirm the impact of the leadership change on ongoing strategic initiatives and operational stability.